Advertisement
XOMA Royalty Corp.

XOMA Royalty Corp. (XOMA) Stock Overview

Explore XOMA Royalty Corp.โ€™s financial performance, market position, analyst ratings, and future outlook.

XOMAโ—NASDAQ
HealthcareBiotechnology
$41.80
$0.12(0.29%)
U.S. Market is Open ยท 14:47
Advertisement

XOMA Royalty Corp. (XOMA)

Meyka AI Score

Z

Key Financials

Market Cap526.1M
P/E Ratio15.76
EPS (TTM)$1.57
ROE0.30%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

XOMA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of XOMA Royalty Corp. (XOMA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.95, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.76 and a market capitalization of 526.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.45%
5-Day Change
-1.28%
1-Month Change
-0.31%
3-Month Change
53.08%
6-Month Change
21.54%
Year-to-Date (YTD) Change
57.05%
1-Year Change
67.04%
3-Year Change
140.83%
5-Year Change
36.43%
All-Time (Max) Change
-99.18%

Contact Information

510 204 7200
2200 Powell Street, EmeryVille, CA, 94608

Company Facts

130 Employees
IPO DateJun 6, 1986
CountryUS
Actively Trading

Frequently Asked Questions